Shinya Yamanaka is one of my favorite fellow scientists. His research is creative and rigorous along with having huge clinical implications. At the same time, Dr. Yamanaka sees the big picture and he’s very open about talking about real life as a scientist. I really appreciate both levels. In the past I interviewed him for […]
Takeaways from new Yamanaka (山中伸弥) stem cell interview Read More »
It’s been a busy few weeks for the stem cell field. Below are some news briefs on developments. RetractionWatch reports that Piero Anversa is leaving Harvard/Brigham and Women’s Hospital after an investigation and dismissed lawsuit he filed against the institution. All still quiet on the STAP cell front at the same institutions. There’s some more
Stem Cell News Briefs: Anversa, Japan Regs, Ocata Suit, More Read More »
By Heather Main (from Stem Cell Meeting on the Mesa) Mesa, one of my first Spanish words since moving to California. The isolated flat-topped hill with steep sides where I have just had the pleasure of listening to some of the best basic and applied science. Mountains of various sorts formed the metaphor of CIRM
Stem Cell Meeting on the Mesa: Highlights from Heather Main Read More »
It’s Friday so time for another one of my TGIF science reads, links, and in this case, videos. The Myth of Beer Goggles? from Neuroskeptic. No drinking (even TGIF drinking) doesn’t necessarily make people seem more attractive…research from the field (bars). Interesting insights from search committee chair on who gets the faculty jobs. Some surprises? Faculty
Science TGIF: useful, fun sciency videos & stuff Read More »
Ready for some stem cell good news? It can be difficult at times in a cutting edge field like stem cells in terms of keeping upbeat about hopes of rapid translation to help patients with real, proven therapies. It takes a long time, money, dedication, and even a bit of luck for the researchers and
6 recent stem cell good news stories including on liver disease Read More »
The path to the clinic is a slow and arduous activity, frustrating not only to the researcher and patient, but investors and biotech companies. Successful clinical translation of technologies requires a balance of science, streamlined translation and funding. To develop fantastic science and then realise the most important components cannot be adapted to the clinical
Biotech Talks #ISSCR2015: StemCells Inc, Semma, ViaCyte, & Le Blanc Read More »
By David Brafman (from a stem cell clinic infomercial event). With the vast amount of information about stem cells available to the general public, many misconceptions exist regarding stem cells and their potential applications. Paul and other prominent stem cell scientists have done an excellent job of educating the public about the facts regarding stem
David Brafman: Attending Stem Cell Clinic Infomercial Read More »
I recently interviewed leading genomics scientist George Church on the ways that trends in genomics are changing our world. We also discussed the possibility of heritable human genetic modification. These days we more often call this “CRISPR babies.” His answers suggest that genomics and gene editing are poised to radically change our world. They could literally
George Church on Germline Human Genetic Modification Read More »
It’s been exciting to watch the recent developments in using stem cells as the basis for treatments for Type I Diabetes. One of the major players in this arena is the privately-held company, ViaCyte. In this post, I interview ViaCyte President and CEO, Paul Laikind. The topics include their VC-01 product, the Encaptra device, an update on
ViaCyte CEO Laikind Interview: Trial Update, Melton, & Future Read More »
2015 Review of Vogelstein “Bad Luck” Cancer & Stem Cell Paper in Science January 02, 2015 2014 What Does New Paper Mean for Future of Nuclear Transfer ES Cells? November 9, 2014 Encouraging New Paper on ACT Stem Cell-Based Trial for Macular Degeneration October 14, 2014 Top 10 Takeaways From Harvard Stem Cell Diabetes
Post-Publication Paper Reviews & Commentaries Read More »